BCDA vs CI · $14.4M cap vs P/E 2.4, rev $274.90B
Biocardia Inc (BCDA) versus Cigna Corp (CI) — a side-by-side from cached financials, not a winner call.
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
Cigna Corp (CI) is a healthcare plans company listed on US.
BCDA does not have a complete income-statement cache yet.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
BCDA currently screens at market cap $14.4M. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Not investment advice. Open the BCDA and CI stock pages for the full models.
Not investment advice.